1 / 11

Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027

Market participants such as GlaxoSmithKline Plc, Novavax, Inc., Statens Serum Institut, Viscogel AB, VaxLiant LLC, Aphios Corporation, Moderna Inc., Sanofi Pasteur, Adjuvatis, Avanti Polar Lipids, Inc., MPV Technologies, CSL Limited, Vaxine Pty Ltd, SPI Pharma, CureVac AG, Sergeant Adjuvants, Agenus, Inc., OZ Biosciences, Adjuvants Unlimited Inc., and Adjuvants Euclid Canada Inc. are some of the key players operating in the concerned market.

karishmamtip
Download Presentation

Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Vaccine Adjuvants Market Set to Exceed $1,305.7 Million By 2027 | CAGR 10.68%

  2. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 “Vaccine Adjuvants Market Share, Size, Trends, Industry Analysis Report, By Product Type (Mineral Salt-based Adjuvant, Tensoactive Adjuvants, Adjuvant Emulsions, Liposome Adjuvants, Carbohydrate Adjuvants, Bacteria-derived Adjuvants, Virus-like Particles (VLP), and Other Types); By Route of Administration (Oral, Subcutaneous, Intranasal, Intramuscular, Intradermal, and Others); By Disease Types; By Application (Research Application and Commercial Application), By Regions; Segment Forecast, 2020 –2027” The global Vaccine Adjuvants Market size is expected to reach USD 1,305.7 million by 2027 according to a new study by Polaris Market Research. Adjuvant is defined as a substance which in combination with vaccine invigorates antigen specific immune reactions to increase specificity and immunogenicity of marketed vaccines administered in any individual. Adjuvants augment the impact of a vaccine providing increased immunity towards any particular infectious disease. It triggers positive immune response by mimicking pathogen associated molecular pattern (PAMP), which include lipo-polysaccharide, liposomes, cell walls of bacteria, and endo-cytosed and un-methylated nucleic acids. Adjuvant imparts beneficial effects to vaccines in several ways such as increasing its potency to grasp the higher degree of immunogenicity, reducing the number of repeated vaccinations, antigen dose reduction, widening antibody responses of the individual, and inducing T-cell responses. Browse Detailed Research Report On Vaccine Adjuvants Market Analysis: https://www.polarismarketresearch.com/industry-analysis/vaccine-adjuvants-market The global market is driven by the recent surge in infectious diseases, extensive research on vaccines, and funding from the government. European Union (EU) through EU programme Horizon 2020, has formed ENOVA, a network on vaccine adjuvants. This will bring both industry experts and stakeholders working in the areas of vaccine research and development and adjuvant research to reduce side effects and efficacy of new developing vaccines. Market participants such as GlaxoSmithKline Plc, Novavax, Inc., Statens Serum Institut, Viscogel AB, VaxLiant LLC, Aphios Corporation, Moderna Inc., Sanofi Pasteur, Adjuvatis, Avanti Polar Lipids, Inc., MPV Technologies, CSL Limited, Vaxine Pty Ltd, SPI Pharma, CureVac AG, Sergeant Adjuvants, Agenus, Inc., OZ Biosciences, Adjuvants Unlimited Inc., and Adjuvants Euclid Canada Inc. are some of the key players operating in the concerned market. Request for sample: https://www.polarismarketresearch.com/industry-analysis/vaccine- adjuvants-market/request-for-sample - 2 -

  3. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 To speed up the process of nCOV vaccine development big players are collaborating with industry stakeholders. In February 2020, GSK and Coalition for Epidemic Preparedness Innovations (CEPI) collaborated to ease the out nCOV vaccine development with GSK’s vaccine adjuvant platform for other players in vaccine development. Similarly, in March 2020, iBio, a contract research organization (CRO) signed a definitive agreement with the Infectious Disease Research Institute (IDRI). The combination of iBio’s VLP antigen with the latter adjuvant expected to offer promising efficacy and safety characteristics. TABLE OF CONTENTS 1. Introduction 1.1. Report Description 1.1.1. Objectives of the Study 1.1.2. Market Scope 1.1.3. Assumptions 1.2. Stakeholders 2. Executive Summary 2.1. Market Highlights 3. Research Methodology 3.1. Overview 3.1.1. Data Mining 3.2. Data Sources 3.2.1. Primary Sources 3.2.2. Secondary Sources 4. Vaccine Adjuvants Market Insights 4.1. Vaccine Adjuvant – Industry snapshot 4.2. Vaccine Adjuvants Market Dynamics 4.2.1. Drivers and Opportunities 4.2.1.1. Surge in the infectious diseases 4.2.1.2. Government sponsored immunization programs 4.2.2. Restraints and Challenges 4.2.2.1. Side effects associated with the usage of adjuvants 4.3. Porter’s Five Forces Analysis 4.3.1. Bargaining Power of Suppliers (Moderate) 4.3.2. Threats of New Entrants: (Low) 4.3.3. Bargaining Power of Buyers (Moderate) 4.3.4. Threat of Substitute (Moderate) 4.3.5. Rivalry among existing firms (High) 4.4. PESTLE Analysis 4.5. Vaccine Adjuvants Market Industry trends 5. Vaccine Adjuvants Market Assessment by Product Type 5.1. Key Findings 5.2. Introduction 5.2.1. Global Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million) 5.3. Mineral Salt-based Adjuvant 5.3.1. Global Vaccine Adjuvants Market, by Mineral Salt-based Adjuvant, by Region, 2016- 2027 (USD Million) - 3 -

  4. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 5.4. Tensoactive Adjuvants 5.4.1. Global Vaccine Adjuvants Market, by Tensoactive Adjuvants, by Region, 2016- 2027 (USD Million) 5.5. Adjuvant Emulsions 5.5.1. Global Vaccine Adjuvants Market, by Adjuvant Emulsions, by Region, 2016- 2027 (USD Million) 5.6. Liposome Adjuvants 5.6.1. Global Vaccine Adjuvants Market, by Liposome Adjuvants, by Region, 2016- 2027 (USD Million) 5.7. Carbohydrate Adjuvants 5.7.1. Global Vaccine Adjuvants Market, by Carbohydrate Adjuvants, by Region, 2016- 2027 (USD Million) 5.8. Bacteria-derived Adjuvants 5.8.1. Global Vaccine Adjuvants Market, by Bacteria-derived Adjuvants, by Region, 2016- 2027 (USD Million) 5.9. Virus-like Particles (VLP) 5.9.1. Global Vaccine Adjuvants Market, by Virus-like Particles (VLP), by Region, 2016- 2027 (USD Million) 5.10. Other Types 5.10.1. Global Vaccine Adjuvants Market, by Other Types, by Region, 2016- 2027 (USD Million) 6. Global Vaccine Adjuvants Market, by Route of Administration 6.1. Key Findings 6.2. Introduction 6.2.1. Global Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million) 6.3. Oral 6.3.1. Global Vaccine Adjuvants Market, by Oral, By Region, 2016- 2027 (USD Million) 6.4. Subcutaneous 6.4.1. Global Vaccine Adjuvants Market, by subcutaneous, by Region, 2016- 2027 (USD Million) 6.5. Intranasal 6.5.1. Global Vaccine Adjuvants Market, by Intranasal, by Region, 2016- 2027 (USD Million) 6.6. Intramuscular 6.6.1. Global Vaccine Adjuvants Market, by Intramuscular, by Region, 2016- 2027 (USD Million) 6.7. Intradermal 6.7.1. Global Vaccine Adjuvants Market, by Intradermal, by Region, 2016- 2027 (USD Million) 6.8. Others 6.8.1. Global Vaccine Adjuvants Market, by Others, by Region, 2016- 2027 (USD Million) 7. Global Vaccine Adjuvants Market, by Disease Type 7.1. Key Findings 7.2. Introduction 7.2.1. Global Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million) 7.3. Infectious Diseases 7.3.1. Global Vaccine Adjuvants Market, by Infectious Diseases, By Region, 2016- 2027 (USD Million) 7.4. Rare Diseases - 4 -

  5. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 7.4.1. Global Vaccine Adjuvants Market, by Rare Diseases, by Region, 2016- 2027 (USD Million) 7.5. Cancer 7.5.1. Global Vaccine Adjuvants Market, by Cancer, by Region, 2016- 2027 (USD Million) 7.6. Autoimmune Disorders 7.6.1. Global Vaccine Adjuvants Market, by Autoimmune Disorders, by Region, 2016- 2027 (USD Million) 7.7. Others 7.7.1. Global Vaccine Adjuvants Market, by Others, by Region, 2016- 2027 (USD Million) 8. Vaccine Adjuvants Market Assessment by Application 8.1. Key Findings 8.2. Introduction 8.2.1. Global Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million) 8.3. Research Application 8.3.1. Global Vaccine Adjuvants Market, by Research Application, by Region, 2016- 2027 (USD Million) 8.4. Commercial Application 8.4.1. Global Vaccine Adjuvants Market, by Commercial Application, by Region, 2016- 2027 (USD Million) 9. Vaccine Adjuvants Market Assessment by Geography 9.1. Key findings 9.2. Introduction 9.2.1. Vaccine Adjuvants Market Assessment, By Geography, 2016- 2027 (USD Million) 9.3. Vaccine Adjuvants Market – North America 9.3.1. North America: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.3.2. North America: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.3.3. North America: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million) 9.3.4. North America: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.3.5. Vaccine Adjuvants Market – U.S. 9.3.5.1. U.S.: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.3.5.2. U.S.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.3.5.3. U.S.: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.3.5.4. U.S.: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.3.6. Vaccine Adjuvants Market – Canada 9.3.6.1. Canada: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.3.6.2. Canada.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.3.6.3. Canada: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.3.6.4. Canada: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.4. Vaccine Adjuvants Market – Europe - 5 -

  6. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 9.4.1. Europe: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.4.2. Europe.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.4.3. Europe: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.4.4. Europe: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.4.5. Vaccine Adjuvants Market – UK 9.4.5.1. UK: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.4.5.2. UK.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.4.5.3. UK: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.4.5.4. UK: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.4.6. Vaccine Adjuvants Market – France 9.4.6.1. France: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.4.6.2. France.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.4.6.3. France: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.4.6.4. France: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.4.7. Vaccine Adjuvants Market – Germany 9.4.7.1. Germany: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.4.7.2. Germany.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.4.7.3. Germany: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.4.7.4. Germany: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.4.8. Vaccine Adjuvants Market – Italy 9.4.8.1. Italy: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.4.8.2. Italy.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.4.8.3. Italy: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.4.8.4. Italy: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.4.9. Vaccine Adjuvants Market – Spain 9.4.9.1. Spain: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.4.9.2. Spain.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.4.9.3. Spain: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.4.9.4. Spain: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.4.10. Vaccine Adjuvants Market – Belgium 9.4.10.1. Belgium: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) - 6 -

  7. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 9.4.10.2. Belgium.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.4.10.3. Belgium: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.4.10.4. Belgium: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.4.11. Vaccine Adjuvants Market – Austria 9.4.11.1. Austria: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.4.11.2. Austria.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.4.11.3. Austria: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.4.11.4. Austria: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.5. Vaccine Adjuvants Market – Asia-Pacific 9.5.1. Asia Pacific: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.5.2. Asia Pacific.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.5.3. Asia-pacific: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.5.4. Asia-pacific: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.5.5. Vaccine Adjuvants Market – China 9.5.5.1. China: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.5.5.2. China.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.5.5.3. China: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.5.5.4. China: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.5.6. Vaccine Adjuvants Market – India 9.5.6.1. India: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.5.6.2. India.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.5.6.3. India: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.5.6.4. India: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.5.7. Vaccine Adjuvants Market – Malaysia 9.5.7.1. Malaysia: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.5.7.2. Malaysia.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.5.7.3. Malaysia: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.5.7.4. Malaysia: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.5.8. Vaccine Adjuvants Market – Japan 9.5.8.1. Japan: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) - 7 -

  8. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 Japan.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.5.8.3. Japan: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.5.8.4. Japan: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.5.9. Vaccine Adjuvants Market – South Korea 9.5.9.1. South Korea: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.5.9.2. South Korea.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.5.9.3. South Korea: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.5.9.4. South Korea: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.5.10. Vaccine Adjuvants Market – Australia 9.5.10.1. Australia: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.5.10.2. Australia.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.5.10.3. Australia: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.5.10.4. Australia: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.6. Vaccine Adjuvants Market – Middle East & Africa 9.6.1. Middle East & Africa: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.6.2. Middle East & Africa.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.6.3. Middle East & Africa: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.6.4. Middle East & Africa: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.6.5. Vaccine Adjuvants Market – Saudi Arabia 9.6.5.1. Saudi Arabia: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.6.5.2. Saudi Arabia.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.6.5.3. Saudi Arabia: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.6.5.4. Saudi Arabia: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.6.6. Vaccine Adjuvants Market – UAE 9.6.6.1. UAE: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.6.6.2. UAE.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.6.6.3. UAE: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.6.6.4. UAE: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.6.7. Vaccine Adjuvants Market – Israel 9.5.8.2. - 8 -

  9. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 Israel: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.6.7.2. Israel.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.6.7.3. Israel: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.6.7.4. Israel: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.6.8. Vaccine Adjuvants Market – South Africa 9.6.8.1. South Africa: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.6.8.2. South Africa.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.6.8.3. South Africa: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.6.8.4. South Africa: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.7. Vaccine Adjuvants Market – Latin America 9.7.1. Latin America: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.7.2. Latin America.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.7.3. Latin America: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.7.4. Latin America: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.7.5. Vaccine Adjuvants Market – Mexico 9.7.5.1. Mexico: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.7.5.2. Mexico.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.7.5.3. Mexico: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.7.5.4. Mexico: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.7.6. Vaccine Adjuvants Market – Brazil 9.7.6.1. Brazil: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.7.6.2. Brazil.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.7.6.3. Brazil: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.7.6.4. Brazil: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 9.7.7. Vaccine Adjuvants Market – Argentina 9.7.7.1. Argentina: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million) 9.7.7.2. Argentina.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million) 9.7.7.3. Argentina: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million) 9.6.7.1. - 9 -

  10. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 Argentina: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million) 10. Competitive Landscape 10.1. Expansion and Acquisition Analysis 10.1.1. Expansion 10.1.2. Acquisitions 10.2. Partnerships/Collaborations/Agreements/Exhibitions 11. Company Profiles 11.1. GlaxoSmithKline Plc 11.1.1. Company Overview 11.1.2. Product Benchmarking 11.1.3. Financial Performance 11.1.4. Recent Development 11.2. Moderna Inc. 11.2.1. Company Overview 11.2.2. Product Benchmarking 11.2.3. Financial Performance 11.2.4. Recent Development 11.3. Sanofi Pasteur 11.3.1. Company Overview 11.3.2. Product Benchmarking 11.3.3. Financial Performance 11.3.4. Recent Development 11.4. Adjuvatis 11.4.1. Company Overview 11.4.2. Product Benchmarking 11.4.3. Financial Performance 11.4.4. Recent Development 11.5. SPI Pharma 11.5.1. Company Overview 11.5.2. Product Benchmarking 11.5.3. Financial Performance 11.5.4. Recent Development 11.6. Novavax, Inc. 11.6.1. Company Overview 11.6.2. Product Benchmarking 11.6.3. Financial Performance 11.6.4. Recent Development 11.7. Sergeant Adjuvants 11.7.1. Company Overview 11.7.2. Product Benchmarking 11.7.3. Financial Performance 11.7.4. Recent Development 11.8. OZ Biosciences 11.8.1. Company Overview 11.8.2. Product Benchmarking 11.8.3. Financial Performance 11.8.4. Recent Development 11.9. Adjuvants Euclid Canada Inc. 11.9.1. Company Overview 11.9.2. Product Benchmarking 11.9.3. Financial Performance 9.7.7.4. - 10 -

  11. Vaccine Adjuvants Market Size Worth $1,305.7 Million By 2027 11.9.4. Recent Development 11.10. Adjuvants Unlimited Inc. 11.10.1. Company Overview 11.10.2. Product Benchmarking 11.10.3. Financial Performance 11.10.4. Recent Development 11.11. Aphios Corporation 11.11.1. Company Overview 11.11.2. Product Benchmarking 11.11.3. Financial Performance 11.11.4. Recent Development Access Press Release on Vaccine Adjuvants Market: https://www.polarismarketresearch.com/press-releases/vaccine-adjuvants-market About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com/ - 11 -

More Related